Qinghai Spring Medicinal Resources Technology CoLTD operates in the Bituminous coal and lignite--surface sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Qinghai Spring Medicinal Resources Technology CoLTD with three other
coal companies in Asia:
Vinacomin NuiBeo Coal JSC
sales of 1.49 trillion Dong [US$63.81 million]
Rosan Resources Holdings Limited
of Hong Kong
(529.88 million Hong Kong Dollars [US$67.62 million]
Resource Alam Indonesia Tbk PT
based in Indonesia
(1.12 trillion Indonesian Rupiahs [US$73.88 million]
Qinghai Spring Medicinal Resources Technology CoLTD reported sales of 470.92 million Chinese Renmimbi (US$68.13 million)
December of 2017.
decrease of 33.5%
versus 2016, when the company's sales were 707.95 million Chinese Renmimbi.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Qinghai Spring Medicinal Resources Technology CoLTD had sales
of 514.26 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 40.1% decline
in Utilization of Medicinal Resources, from 411.87 million Chinese Renmimbi to 246.76 million Chinese Renmimbi.
There were also decreases in sales in
Advertising Business (down 16.5% to 224.35 million Chinese Renmimbi)